As of June 3, 2025, Aequus Pharmaceuticals Inc (AQS.V) reports a Net Margin of -372.73%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Aequus Pharmaceuticals Inc's Net Margin
Over recent years, Aequus Pharmaceuticals Inc's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | -372.73% |
| 2023-12-31 | -1163.09% |
| 2022-12-31 | -232.65% |
| 2021-12-31 | -66.66% |
| 2020-12-31 | -40.32% |
This slight upward trend highlights how Aequus Pharmaceuticals Inc manages its overall profitability and cost control over time.
Comparing Aequus Pharmaceuticals Inc's Net Margin to Peers
To better understand Aequus Pharmaceuticals Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Aequus Pharmaceuticals Inc (AQS.V) | -372.73% |
| Biostem Technologies Inc (BSEM) | 10.56% |
| SugarBud Craft Growers Corp (SUGR.V) | 3.57% |
| Nexien Biopharma Inc (NXEN) | -8.56% |
| Nextleaf Solutions Ltd (OILS.CN) | -11.51% |
| Avricore Health Inc (AVCR.V) | -13.98% |
Compared to its competitors, Aequus Pharmaceuticals Inc's Net Margin is about average compared to peers, reflecting typical industry profitability.